Evidence map›Paper›PMID 28373281›Full record

ArticleThe Journal of biological chemistry2017

An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody.

Mykhailo Y Batiuk, Filip de Vin, Sandra I Duqué, Chen Li, Takashi Saito, Takaomi Saido, Mark Fiers, T Grant Belgard, Matthew G Holt

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Upregulation of adenosine AMolecular psychiatry · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Mykhailo Y BatiukFrom the Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research.
Filip de VinFrom the Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research.
Sandra I DuquéFrom the Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research.
Chen LiFrom the Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research.
Takashi Saitothe Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama 351-0106, Japan, and.
Takaomi Saidothe Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama 351-0106, Japan, and.
Mark Fiersthe VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
T Grant Belgardthe Medical Research Council Functional Genomics Unit, Department of Physiology, Anatomy, and Genetics, University of Oxford, South Parks Road, Oxford OX1 3PT, United Kingdom.
Matthew G HoltFrom the Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research, Matthew.Holt@kuleuven.vib.be.
VIB-KU Leuven Center for Brain & Disease Research · BEKU Leuven · BERIKEN Center for Brain Science · JPGenomics (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes are a major cell type in the mammalian CNS. Astrocytes are now known to play a number of essential roles in processes including synapse formation and function, as well as blood-brain barrier formation and control of cerebral blood flow. However, our understanding of the molecular mechanisms underlying astrocyte development and function is still rudimentary. This lack of knowledge is at least partly due to the lack of tools currently available for astrocyte biology. ACSA-2 is a commercially available antibody originally developed for the isolation of astrocytes from young postnatal mouse brain, using magnetic cell-sorting methods, but its utility in isolating cells from adult tissue has not yet been published. Using a modified protocol, we now show that this tool can also be used to isolate ultrapure astrocytes from the adult brain. Furthermore, using a variety of techniques (including single-cell sequencing, overexpression and knockdown assays, immunoblotting, and immunohistochemistry), we identify the ACSA-2 epitope for the first time as ATP1B2 and characterize its distribution in the CNS. Finally, we show that ATP1B2 is stably expressed in multiple models of CNS injury and disease. Hence, we show that the ACSA-2 antibody possesses the potential to be an extremely valuable tool for astrocyte research, allowing the purification and characterization of astrocytes (potentially including injury and disease models) without the need for any specialized and expensive equipment. In fact, our results suggest that ACSA-2 should be a first-choice method for astrocyte isolation and characterization.

Indexed as

Adenosine TriphosphatasesCation Transport ProteinsCell Adhesion Molecules, NeuronalEpitopesGene Expression RegulationAnimalsAntibodiesAstrocytesBrainBrain InjuriesDisease Models, AnimalFemaleMaleMiceAdenosine TriphosphatasesAntibodiesAtp1b2 protein, mouseCation Transport ProteinsCell Adhesion Molecules, NeuronalEpitopesastrocytecell surface proteinflow cytometryimmunoblottingimmunohistochemistryimmunoisolationmembrane proteinneuroscienceplasma membranesingle-cell RNA-seq

Identifiers

PMID28373281
PMCPMC5448122
OpenAlexW2605170081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.